These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 34944416)

  • 1. The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor.
    Bharadwaj AG; Kempster E; Waisman DM
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
    Kwon M; MacLeod TJ; Zhang Y; Waisman DM
    Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin A2-S100A10 heterotetramer is upregulated by PML/RARα fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia.
    Huang D; Yang Y; Sun J; Dong X; Wang J; Liu H; Lu C; Chen X; Shao J; Yan J
    Front Med; 2017 Sep; 11(3):410-422. PubMed ID: 28687976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10.
    Madureira PA; Bharadwaj AG; Bydoun M; Garant K; O'Connell P; Lee P; Waisman DM
    Oncotarget; 2016 Jul; 7(30):47720-47737. PubMed ID: 27351226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the annexin A2 heterotetramer in vascular fibrinolysis.
    Madureira PA; Surette AP; Phipps KD; Taboski MA; Miller VA; Waisman DM
    Blood; 2011 Nov; 118(18):4789-97. PubMed ID: 21908427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin.
    MacLeod TJ; Kwon M; Filipenko NR; Waisman DM
    J Biol Chem; 2003 Jul; 278(28):25577-84. PubMed ID: 12730231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis.
    Madureira PA; O'Connell PA; Surette AP; Miller VA; Waisman DM
    J Biomed Biotechnol; 2012; 2012():353687. PubMed ID: 23118506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annexin A2-S100A10 heterotetramer, a novel substrate of thioredoxin.
    Kwon M; Yoon CS; Jeong W; Rhee SG; Waisman DM
    J Biol Chem; 2005 Jun; 280(25):23584-92. PubMed ID: 15849182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Annexin A2/S100A10 Complex: The Mutualistic Symbiosis of Two Distinct Proteins.
    Bharadwaj A; Kempster E; Waisman DM
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of plasmin generation by S100A10.
    Miller VA; Madureira PA; Kamaludin AA; Komar J; Sharma V; Sahni G; Thelwell C; Longstaff C; Waisman DM
    Thromb Haemost; 2017 Jun; 117(6):1058-1071. PubMed ID: 28382372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the contribution of S100A10 and annexin A2 to plasminogen activation and oncogenesis: an enduring ambiguity.
    Bydoun M; Waisman DM
    Future Oncol; 2014 Dec; 10(15):2469-79. PubMed ID: 25525855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple functions of S100A10, an important cancer promoter.
    Saiki Y; Horii A
    Pathol Int; 2019 Nov; 69(11):629-636. PubMed ID: 31612598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target.
    Sharma MC; Sharma M
    Curr Pharm Des; 2007; 13(35):3568-75. PubMed ID: 18220793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of S100A10 by the PML-RAR-α oncoprotein.
    O'Connell PA; Madureira PA; Berman JN; Liwski RS; Waisman DM
    Blood; 2011 Apr; 117(15):4095-105. PubMed ID: 21310922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen receptors and their role in the pathogenesis of inflammatory, autoimmune and malignant disease.
    Godier A; Hunt BJ
    J Thromb Haemost; 2013 Jan; 11(1):26-34. PubMed ID: 23140188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Ion Channels and Receptors by p11 (S100A10).
    Seo JS; Svenningsson P
    Trends Pharmacol Sci; 2020 Jul; 41(7):487-497. PubMed ID: 32418644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells.
    Hou Y; Yang L; Mou M; Hou Y; Zhang A; Pan N; Qiang R; Wei L; Zhang N
    Cancer Invest; 2008 Oct; 26(8):809-15. PubMed ID: 18608216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of fibrinolysis by S100A10 in vivo.
    Surette AP; Madureira PA; Phipps KD; Miller VA; Svenningsson P; Waisman DM
    Blood; 2011 Sep; 118(11):3172-81. PubMed ID: 21768297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer.
    Noye TM; Lokman NA; Oehler MK; Ricciardelli C
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mechanism of plasminogen activation in epithelial and mesenchymal cells.
    Bydoun M; Sterea A; Weaver ICG; Bharadwaj AG; Waisman DM
    Sci Rep; 2018 Sep; 8(1):14091. PubMed ID: 30237490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.